Literature DB >> 8560980

Microglial cells and amyloid beta protein (A beta) deposition; association with A beta 40-containing plaques.

D M Mann1, T Iwatsubo, H Fukumoto, Y Ihara, A Odaka, N Suzuki.   

Abstract

Two distinct species of amyloid beta protein (A beta) with different carboxyl termini, A beta 40 and A beta 42(43), are deposited in plaques in the brains of patients with Alzheimer's disease and Down's syndrome. The relationship between these two forms of A beta and microglial cells was investigated in 16 subjects with Down's syndrome ranging in age from 31 to 64 years. The amount of A beta 40 in plaques was low in persons under 50 years of age, even though high amounts of A beta 42(43) were present. Microglia were observed most commonly in plaques containing both A beta 40 and A beta 42(43) but less commonly in those with A beta 42(43) alone. The presence of microglial cells in plaques may be associated with the accumulation of A beta 40 and these cells may have a role in the production or processing of this particular molecular species.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8560980     DOI: 10.1007/bf00294808

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  28 in total

1.  The complex of microglial cells and amyloid star in three-dimensional reconstruction.

Authors:  J Wegiel; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.

Authors:  P Cras; M Kawai; S Siedlak; P Mulvihill; P Gambetti; D Lowery; P Gonzalez-DeWhitt; B Greenberg; G Perry
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

3.  Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

Authors:  S Itagaki; P L McGeer; H Akiyama; S Zhu; D Selkoe
Journal:  J Neuroimmunol       Date:  1989-10       Impact factor: 3.478

4.  An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain.

Authors:  A D Snow; R Sekiguchi; D Nochlin; P Fraser; K Kimata; A Mizutani; M Arai; W A Schreier; D G Morgan
Journal:  Neuron       Date:  1994-01       Impact factor: 17.173

5.  Inability to detect beta-amyloid protein precursor mRNA in Alzheimer plaque-associated microglia.

Authors:  S A Scott; S A Johnson; C Zarow; L S Perlmutter
Journal:  Exp Neurol       Date:  1993-05       Impact factor: 5.330

6.  Polyclonals to beta-amyloid(1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum.

Authors:  K Mak; F Yang; H V Vinters; S A Frautschy; G M Cole
Journal:  Brain Res       Date:  1994-12-19       Impact factor: 3.252

7.  beta-Amyloid peptide produced in vitro is degraded by proteinases released by cultured cells.

Authors:  A Naidu; D Quon; B Cordell
Journal:  J Biol Chem       Date:  1995-01-20       Impact factor: 5.157

Review 8.  Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease.

Authors:  D W Dickson; S C Lee; L A Mattiace; S H Yen; C Brosnan
Journal:  Glia       Date:  1993-01       Impact factor: 7.452

9.  Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion.

Authors:  C Haass; A Y Hung; D J Selkoe
Journal:  J Neurosci       Date:  1991-12       Impact factor: 6.167

10.  Microglia in diffuse plaques in hereditary cerebral hemorrhage with amyloidosis (Dutch). An immunohistochemical study.

Authors:  M L Maat-Schieman; A J Rozemuller; S G van Duinen; J Haan; P Eikelenboom; R A Roos
Journal:  J Neuropathol Exp Neurol       Date:  1994-09       Impact factor: 3.685

View more
  8 in total

Review 1.  Alzheimer's disease.

Authors:  Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

2.  Beta-amyloid protein structure determines the nature of cytokine release from rat microglia.

Authors:  Catharina Lindberg; Maj-Linda Bardyl Selenica; Anita Westlind-Danielsson; Marianne Schultzberg
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 3.  What is the dominant Abeta species in human brain tissue? A review.

Authors:  Gillian C Gregory; Glenda M Halliday
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

4.  Microglial response to amyloid plaques in APPsw transgenic mice.

Authors:  S A Frautschy; F Yang; M Irrizarry; B Hyman; T C Saido; K Hsiao; G M Cole
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

5.  Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.

Authors:  D M Mann; T Iwatsubo; Y Ihara; N J Cairns; P L Lantos; N Bogdanovic; L Lannfelt; B Winblad; M L Maat-Schieman; M N Rossor
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

6.  Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis.

Authors:  Mingqin Zhu; Xiuzhe Wang; Erik Hjorth; Romain A Colas; Lisa Schroeder; Ann-Charlotte Granholm; Charles N Serhan; Marianne Schultzberg
Journal:  Mol Neurobiol       Date:  2015-12-09       Impact factor: 5.590

7.  Amyloid beta protein deposition in normal aging has the same characteristics as that in Alzheimer's disease. Predominance of A beta 42(43) and association of A beta 40 with cored plaques.

Authors:  H Fukumoto; A Asami-Odaka; N Suzuki; H Shimada; Y Ihara; T Iwatsubo
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

Review 8.  A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome.

Authors:  Frances K Wiseman; Tamara Al-Janabi; John Hardy; Annette Karmiloff-Smith; Dean Nizetic; Victor L J Tybulewicz; Elizabeth M C Fisher; André Strydom
Journal:  Nat Rev Neurosci       Date:  2015-08-05       Impact factor: 34.870

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.